logo
15:59 Dec 05

Bliss GVS Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
171.23
+4.36 (+2.61%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Bliss GVS Pharma Ltd. Financials

Bliss GVS Pharma Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
171.23
+4.36 (+2.61%)
15:59 Dec 05
Quality
image/svg+xml

59/100
High Financial Strength

Valuation
image/svg+xml

54/100
Affordable Valuation

Technical

65/100
Technically Moderately Bullish

Strength

11

Weakness

3

Opportunity

1

Threats

0

8.02 %

ROE %

6.48 %

ROA %

10.37

EPS

99.68

BVPS

10.41 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
747.45 751.59 770.24 809.73 833.56
Operating Expenses +
629.12 634.27 619.62 683.04 699.85
Raw Material
420.18 374.38 390.47 421.79 432.39
Increase Decrease in Cost
-29.2 26.94 -8.35 -8.11 -11.97
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
76.15 86.17 95.58 112.05 116.51
Miscellaneous Expenses
231.81 235.46 244.62 255.87 162.92
Operating Profit
118.33 117.32 150.62 126.69 133.71
Other Income
31.49 17.79 28.74 36.49 67.83
Depreciation
17.33 18.67 26.38 29.42 30.77
Interest
4.74 10.36 6.91 8.12 12.06
Profit before tax and exceptio..
127.76 106.07 146.07 125.64 158.71
Exceptional Items
-73.59 0 -29.2 0 0
PBT
54.17 106.07 116.87 125.64 158.71
Provision for Taxation
31.04 29.34 35.29 35.38 46.17
Net Profit
23.13 76.73 81.58 90.26 112.5
NET Profit after MI
15.04 70.86 75.45 84.3 106.64
EPS
1.46 6.72 7.23 7.95 10.13
Operating Profit Margin (%)
15.83 15.61 19.55 15.65 16.04
Net Profit Margin (%)
2.01 9.43 9.8 10.41 12.79

Bliss GVS Pharma Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 35.40 35.40 35.30 35.10 34.80 34.90
FII 13.30 12.60 13.20 13.50 12.10 13.20
Public 5.90 6.60 6.50 6.60 6.60 6.60
Others 45.40 45.40 45.00 44.80 46.50 45.30
Shareholder Shares Holding %
Research 360 logo
Download Our App On: